Inventor · disambiguated record
Mario Ehlers
Also filed as: EHLERS MARIO · EHLERS MARIO R W
10 granted patents·4 pending applications·670 citations·filing 1999–2017
93Inventor score
Top patents by PatentIndex Score
14 records- 0197US6982248B2Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissueAMYLIN PHARMACEUTICALS INC·Filed 2001·Granted Jan 3, 2006·78 cites·28 claims
- 0297US6706689B2Treatment of acute coronary syndrome with GLP-1AMYLIN PHARMACEUTICALS INC·Filed 2001·Granted Mar 16, 2004·142 cites·41 claims
- 0397US6284725B1Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissueBIONEBRASKA INC·Filed 1999·Granted Sep 4, 2001·186 cites·13 claims
- 0496US6894024B2Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptideAMYLIN PHARMACEUTICALS INC·Filed 2001·Granted May 17, 2005·91 cites·9 claims
- 0595US7056887B2Treatment of acute coronary syndrome with GLP-1AMYLIN PHARMACEUTICALS INC·Filed 2002·Granted Jun 6, 2006·59 cites·12 claims
- 0691US8551947B2Treatment of hibernating myocardium with an exendin peptideCOOLIDGE THOMAS R·Filed 2010·Granted Oct 8, 2013·14 cites·12 claims
- 0791US7981861B2Method of performing angioplasty with a GLP-1 moleculeAMYLIN PHARMACEUTICALS INC·Filed 2010·Granted Jul 19, 2011·14 cites·8 claims
- 0888US6429197B1Metabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brainBIONEBRASKA INC·Filed 1999·Granted Aug 6, 2002·68 cites·10 claims
- 0985USRE41288EMetabolic intervention with GLP-1 or its biologically active analogues to improve the function of the ischemic and reperfused brainAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Apr 27, 2010·18 cites·29 claims
- 1059US2004033532A1Use of three-dimensional crystal structure coordinates to design and synthesize domain-selective inhibitors for angiotensin-converting enzyme (ACE)Filed 2003·Application pending·0 cites
- 1157US2005096276A1Treatment of hibernating myocardium with a GLP-1 peptideFiled 2004·Application pending·0 cites
- 1257US2006035836A1Treatment of acute coronary syndrome with an exendinAMYLIN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1356US2002147131A1Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused skeletal muscle tissueFiled 2001·Application pending·0 cites
- 1449US11129805B2Dual ACE C-domain/NEP inhibitorsANGIODESIGN UK LTD·Filed 2017·Granted Sep 28, 2021·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →